Difference between revisions of "File:Fig7 Maury FrontDigHlth2021 3.jpg"
Shawndouglas (talk | contribs) (Added summary.) |
Shawndouglas (talk | contribs) |
||
Line 1: | Line 1: | ||
==Summary== | ==Summary== | ||
{{Information | {{Information | ||
|Description='''Figure 7.''' SARS-CoV-2 RT-PCR systems introduced in our laboratory. RT-PCR for the detection of SARS-CoV-2 from clinical specimens were achieved using several instruments introduced in our laboratory. The in-house molecular diagnostic platform (Molecular Dx platform) and the cobas SARS-CoV-2 instrument are two high-throughput RT-PCR systems, while the Xpert Xpress SARS-CoV-2 assay (Cepheid, CA, USA) and the cobas SARS-CoV-2-Influenza A/B test are rapid RT-PCR systems used for emergencies, adapted from Opota ''et al.'' | |Description='''Figure 7.''' SARS-CoV-2 RT-PCR systems introduced in our laboratory. RT-PCR for the detection of SARS-CoV-2 from clinical specimens were achieved using several instruments introduced in our laboratory. The in-house molecular diagnostic platform (Molecular Dx platform) and the cobas SARS-CoV-2 instrument are two high-throughput RT-PCR systems, while the Xpert Xpress SARS-CoV-2 assay (Cepheid, CA, USA) and the cobas SARS-CoV-2-Influenza A/B test are rapid RT-PCR systems used for emergencies, adapted from Opota ''et al.'' and Marquis ''et al.'' | ||
|Source={{cite journal |title=An automated dashboard to improve laboratory COVID-19 diagnostics management |journal=Frontiers in Digital Health |author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. |volume=3 |at=773986 |year=2021 |doi=10.3389/fdgth.2021.773986}} | |Source={{cite journal |title=An automated dashboard to improve laboratory COVID-19 diagnostics management |journal=Frontiers in Digital Health |author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. |volume=3 |at=773986 |year=2021 |doi=10.3389/fdgth.2021.773986}} | ||
|Author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. | |Author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. |
Latest revision as of 21:58, 17 February 2022
Summary
Description |
Figure 7. SARS-CoV-2 RT-PCR systems introduced in our laboratory. RT-PCR for the detection of SARS-CoV-2 from clinical specimens were achieved using several instruments introduced in our laboratory. The in-house molecular diagnostic platform (Molecular Dx platform) and the cobas SARS-CoV-2 instrument are two high-throughput RT-PCR systems, while the Xpert Xpress SARS-CoV-2 assay (Cepheid, CA, USA) and the cobas SARS-CoV-2-Influenza A/B test are rapid RT-PCR systems used for emergencies, adapted from Opota et al. and Marquis et al. |
---|---|
Source |
Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. (2021). "An automated dashboard to improve laboratory COVID-19 diagnostics management". Frontiers in Digital Health 3: 773986. doi:10.3389/fdgth.2021.773986. |
Date |
2021 |
Author |
Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. |
Permission (Reusing this file) |
|
Other versions |
Licensing
![]() ![]() |
This work is licensed under the Creative Commons Attribution 4.0 License. |
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 21:56, 17 February 2022 | ![]() | 1,084 × 574 (209 KB) | Shawndouglas (talk | contribs) |
You cannot overwrite this file.
File usage
The following 2 pages use this file: